Orthotopic and induced murine HCC models: HCA-1 implanted in C3H mice, RIL-175 (p53/Hras-driven) in C57BL/6 mice, plus a genetically engineered model carrying Mst1/2 mutations. Here, TP53 is linked to hepatocellular carcinoma.